MDRX stock news

AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Read more
Allscripts (MDRX) expects its Veradigm business to drive bookings in 2019. Read more
Allscripts Healthcare Solutions Inc has reached a tentative agreement to pay $145 million to resolve a U.S. Justice Department investigation related to an electronic health records vendor it acquired last year. Read more
Allscripts (MDRX) second-quarter results gain from growth in bookings and solid show by client services segment. Contraction in operating margin remains a woe. Read more
Drugmaker Merck & Co Inc has disclosed that it has received a series of subpoenas as part of a U.S. investigation related to a cloud-based electronic health records company that Allscripts Healthcare Solutions Inc acquired last year. Read more
Livongo, a company that sells diabetes monitoring technology, on Friday filed paperwork to go public with the US Securities and Exchange Commission. The company most recently had a post-money valuation of $800 million. Livongo is seeking to raise up to $200 million in its IPO and achieve a valuation of $2 billion to $2.5 billion, according to a person familiar with the matter. Click here for more BI Prime stories. Livongo, a company that sells diabetes monitoring technology, just filed to go public. The company on Friday filed paperwork with the US Securities and Exchange Commission to trade on the Nasdaq under the ticker symbol LVGO. Livongo plans to raise up to $200 million in its IPO and achieve a valuation of $2 billion to $2.5 billion, according to a person familiar with the matter. The terms of the offering are subject to change as the IPO draws near. Livongo was founded in 2014 and operates diabetes and other chronic disease management programs using a glucose meter and other devices on behalf of big companies and insurers who pay monthly fees. Read more
Allscripts (MDRX) is gaining steadily from strategic acquisitions and solid prospects in Sunrise EHR platform. However, integration risks remain a woe. Read more
This is an excerpt from a story delivered exclusively to Business Insider Intelligence Digital Health Pro subscribers. To receive the full story plus other insights each morning, click here . In an effort to spiff up its line of offerings, electronic health system (EHR) vendor Allscripts snapped up Boston-based specialty drug prescription startup ZappRx, according to MedCity News. While the cost of the deal is unclear, we know ZappRx's price tag was smaller than the $42 million the startup previously raised in venture capital. Now, Allscripts will integrate ZappRx's cloud-based platform — which expedites prescription-related administrative tasks for providers — into its feature that grants providers the ability to prescribe medications digitally. Here's what it means: Extending its scope with new products and dipping into new revenue streams is a good call for Allscripts considering its recent run of speedbumps. A horde of Allscripts' clients jumped ship in favor of powerful competitors. Read more
AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Read more
Allscripts (MDRX) Q1 results gain from growth in bookings and solid show by client services segment. Contraction in margins remains a woe. Read more
Allscripts Healthcare Solutions Inc says an electronic health records vendor it acquired last year has received a federal grand jury subpoena as part of a criminal investigation related to how it obtained government-required software certification. Read more
Start Time: 16:30 End Time: 17:24 Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Q1 2019 Earnings Conference Call May 02, 2019, 16:30 PM ET Company Partici Read more
AllScripts (MDRX) delivered earnings and revenue surprises of 14.29% and -1.02%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Read more

Proudly made at

ROCKIT